PRGO:NYE-Perrigo Company PLC (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 24.93

Change

+0.18 (+0.73)%

Market Cap

N/A

Volume

0.93M

Analyst Target

USD 57.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-0.96 (-0.50%)

USD 88.29B
HLN Haleon plc

-0.03 (-0.29%)

USD 48.57B
TAK Takeda Pharmaceutical Co Ltd A..

+0.19 (+1.33%)

USD 45.08B
RDY Dr. Reddy’s Laboratories Ltd..

-1.30 (-1.63%)

USD 13.46B
CTLT Catalent Inc

-0.12 (-0.20%)

USD 10.91B
ELAN Elanco Animal Health

+0.16 (+1.10%)

USD 7.26B
BHC Bausch Health Companies Inc

+0.05 (+0.60%)

USD 3.05B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.10 (+1.17%)

USD 2.68B
CPHI China Pharma Holdings Inc

-0.01 (-3.86%)

USD 4.41M
YCBD cbdMD Inc

+0.01 (+2.61%)

USD 1.70M

ETFs Containing PRGO

FLWR:SW 15.27 % 0.00 %

N/A

N/A
HLIT:CA Global X Lithium Producer.. 10.39 % 0.00 %

+0.41 (+2.40%)

CAD 0.03B
ION Proshares S&P Global Core.. 3.98 % 0.00 %

+0.73 (+2.40%)

USD 2.24M
SDIP:LSE Global X SuperDividend UC.. 1.21 % 0.00 %

+0.02 (+2.40%)

USD 0.15B
SDIU:LSE Global X SuperDividend UC.. 1.21 % 0.00 %

-0.05 (2.40%)

USD 0.26M
WSRD:CA Wealthsimple Developed Ma.. 1.10 % 0.00 %

-0.09 (2.40%)

CAD 0.70B
GNRX 0.00 % 0.55 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+0.22 (+2.40%)

N/A
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

+0.51 (+2.40%)

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
QDVM:F 0.00 % 0.00 %

N/A

N/A
QDVM:XETRA 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.53% 25% F 9% A-
Dividend Return 1.72% 50% F 34% F
Total Return -20.81% 25% F 9% A-
Trailing 12 Months  
Capital Gain -18.15% 25% F 9% A-
Dividend Return 2.71% 67% D+ 38% F
Total Return -15.45% 25% F 9% A-
Trailing 5 Years  
Capital Gain -53.48% 33% F 9% A-
Dividend Return 8.87% 40% F 29% F
Total Return -44.61% 40% F 9% A-
Average Annual (5 Year Horizon)  
Capital Gain -13.00% N/A N/A 5% F
Dividend Return -10.63% N/A N/A 6% D-
Total Return 2.37% N/A N/A 51% F
Risk Return Profile  
Volatility (Standard Deviation) 8.11% N/A N/A 82% B
Risk Adjusted Return -131.12% N/A N/A N/A F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.